Jabez Biosciences, Inc.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Florida
- Sector
- Biotech
- Headquarters
- Cranberry Twp., PA
- Street
- 2009 Mackenzie
- Zip
- 16066
Offering
- Total offering
- —
- Amount sold
- $31k
- First sale
- Jun 11, 2024
- Min investment
- $100
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 8 (4 accredited · 4 non-accredited)
How this filing compares
Other Pennsylvania filings this week: Barrett Upton Tax-Efficient Income Fund LP, Caprock PSP V LP, Caprock Real Estate Opportunities I LP, Century Park Growth & Income Fund LP, Century Park Income Fund
Leadership
Tamara Jovonovich — Executive Officer (also: Director, Promoter)
Brian Cogley — Executive Officer (also: Director)
Also named on: Nok Therapeutics, Inc.
Robert Lewis — Executive Officer (also: Director, Promoter)
Also named on: Nok Therapeutics, Inc.
Bruce Cassidy — Director
Also named on: Nok Therapeutics, Inc.
Martin Lewis — Director
Also named on: Nok Therapeutics, Inc.
Michael Lewis — Promoter
Also named on: Nok Therapeutics, Inc.
David Mehalick — Promoter
Also named on: Nok Therapeutics, Inc.
Filing details
Jabez Biosciences, Inc. filed a Form D with the SEC on March 26, 2026.